Endoscopic Spinal Surgery Market will surpass US$ 1.4 Bn revenues at a CAGR of 8% towards the end of 2031

Endoscopic Spinal Surgery Market 2022

The global Endoscopic Spinal Surgery Market is estimated to reach US$ 1.4 Bn at a CAGR of 8% by the year 2031. With remote monitoring comes remote surgery. With digital twinning, this surgery becomes feasible. This could help in saving on prices of development of complex medical products, thereby improvising on the time-to-market metric. This would be the thing with the healthcare vertical in the upcoming period.

The global endoscopic spinal surgery market was valued at US$ 573.6 Mn in 2020, and is expected to exhibit a CAGR of over 8% through the forecast period (2021 - 2031).

Get Free Sample Copy Of Endoscopic Spinal Surgery Market Report@ https://www.persistencemarketresearch.com/samples/19993

Rise in cases of spinal surgeries due to growing instances of road accidents has resulted in growth of the market, and an increasing geriatric population will further drive demand over the coming years. There are 1.62 Mn instrumented spinal procedures performed in the U.S. every year.

Also, demand for minimally invasive procedures has increased in the last few years. It is mainly due to less pain and fast recovery. Launch of innovative technologies in the healthcare sector will lead to market growth. A steady growth of investments in emerging economies and better reimbursement policies will attract manufacturers to expand their offering in developing regions.

Company Profiles:

DePuySynthes Spine, Inc. (Johnson & Johnson)Overview
Medtronic PLC.
MedicalTek Co., Ltd.
SchöllyFiberoptic GmbH
Stryker Corporation
Zimmer Biomet Holdings, Inc.
Richard Wolf (RIWOSpine)
Joimax GmbH
Aesculap Implant Systems
Olympus Corporation
Karl Storz
Globus Medical, Inc

Switch Over To The "Methodology" Tab! https://www.persistencemarketresearch.com/methodology/19993

Key Takeaways from Market Study

Endoscopic devices account over 67% market share, globally, as they are used for spinal injury surgeries.
In terms of end user, hospitals contribute to a large share in the market due to higher footfall of patients and number of surgical procedures.
The region of North America is dominant in the global market for endoscopic spinal surgery, and will continue to remain the most lucrative regional market over the forecast period.

"Endoscopic spinal surgery is witnessing growing demand in developed and emerging economies due to high prevalence of spinal injuries and increasing road accidents. Advanced technologies are attracting more end users in this space," says an analyst of Persistence Market Research.

Go To "Purchase Now" To Decipher The Competitive Analysis In Our Endoscopic Spinal Surgery Market Report@ https://www.persistencemarketresearch.com/checkout/19993

Acquisitions and Collaborations- Strategy by Key Players

Key players in the endoscopic spinal surgery space use the strategy of acquisitions and collaborations to expand globally and reach more end users. Introduction of new features is being adopted inducing intense competition among market players.

In June 2019, Medtronics announced a partnership with KARL STORZ SE & Co. KG for its upcoming robotic-assisted surgical platform.

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on the endoscopic spinal surgery market in its latest study, presenting a historical demand assessment of 2016 - 2020 and projections for 2021 - 2031. The research study is based on product, procedure, technology, and end user, across seven key regions of the world.

Access Related Reports-

Malignant Mesothelioma Market - https://www.persistencemarketresearch.com/market-research/malignant-mesothelioma-market.asp

Global malignant mesothelioma market is estimated to represent close to US$ 160 mn, or more than 45% revenue share of the total market in 2017 and more than US$ 300 mn by 2025 end.

Diabetic Gastroparesis Market - https://www.persistencemarketresearch.com/market-research/diabetic-gastroparesis-market.asp

Global diabetic gastroparesis treatment market is expected to register a CAGR of 4.1% over the forecast period and reach a market valuation of US$ 3,769.3 Mn by 2024.

Contact Us:

Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com

About Us: 

PersistenceMarketResearch is an esteemed company with a reputation of serving clients across domains of information technology (IT), healthcare, and chemicals. Our analysts undertake painstaking primary and secondary research to provide a seamless report with a 360 degree perspective. Data is compared against rep/uted organizations, trustworthy databases, and international surveys for producing impeccable reports backed with graphical and statistical information.

This release was published on openPR.